Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-11-02 | "Arie S. Belldegrun, M.D., FACS" was appointed to serve as a director of the Company on September 24, 2009. ... Dr. Belldegrun is Director of the Institute of Urologic Oncology at UCLA... |
| 2010-06-15 | Arie S. Belldegrun, M.D. ... has been a director of Nile since September 2009... The following table sets forth the compensation received by our directors for their service in 2009... Arie Belldegrun, M.D.... Total $136,514. |
| 2011-04-08 | Arie S. Belldegrun, M.D. ... has been a director of Nile since September 2009... The following table sets forth the compensation received by our directors for their service in 2010... Arie S. Belldegrun, M.D.... Total ... $16,876. |
| 2013-10-10 | "Arie S. Belldegrun, M.D., FACS has been a director of Nile since September 2009." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-13